About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Igf1
insulin-like growth factor 1
MGI:96432
85 phenotypes from 9 alleles in 12 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Igf1tm1.1Dlr/Igf1tm1.1Dlr
involves: C57BL/6 * FVB/N
abnormal body size J:69518
abnormal glucose homeostasis J:69518
decreased birth weight J:69518
decreased body length J:69518
decreased circulating glucose level J:69518
increased circulating growth hormone level J:69518
increased circulating insulin level J:69518
insensitivity to growth hormone J:69518
postnatal lethality, incomplete penetrance J:69518
premature death J:49468
prenatal lethality, incomplete penetrance J:69518
slow postnatal weight gain J:49468, J:69518
Igf1tm1.1Nros/Igf1tm1.1Nros
involves: BALB/c * C57BL/6
decreased circulating insulin-like growth factor I level J:159167
normal growth/size/body region phenotype J:159167
normal mortality/aging J:159167
Igf1tm1Arge/Igf1+
involves: 129S/SvEv * MF1
normal hearing/vestibular/ear phenotype J:105536
small cochlear ganglion J:71687
Igf1tm1Arge/Igf1tm1Arge
either: 129S/SvEv-Igf1tm1Arge or (involves: 129S/SvEv * C57BL/6J) or (involves: 129S/SvEv * MF1)
decreased body size J:15108
delayed bone ossification J:15108
neonatal lethality, complete penetrance J:15108
postnatal growth retardation J:15108
Igf1tm1Arge/Igf1tm1Arge
involves: 129S/SvEv
decreased motor neuron number J:103711
Igf1tm1Arge/Igf1tm1Arge
involves: 129S/SvEv * DBA * MF1
abnormal chondrocyte morphology J:66913
abnormal long bone epiphyseal plate proliferative zone J:66913
abnormal long bone hypertrophic chondrocyte zone J:66913
abnormal trabecular bone morphology J:66913
decreased width of hypertrophic chondrocyte zone J:66913
delayed endochondral bone ossification J:66913
increased circulating growth hormone level J:66913
postnatal growth retardation J:66913
proportional dwarf J:66913
Igf1tm1Arge/Igf1tm1Arge
involves: 129S/SvEv * MF1
abnormal auditory brainstem response waveform shape J:105536
abnormal cochlea morphology J:71687
abnormal cochlear ganglion morphology J:71687
abnormal cochlear nerve morphology J:71687
abnormal hair follicle development J:82113
abnormal lung morphology J:82113
abnormal mitral cell morphology J:82113
abnormal myelination J:71687
abnormal olfactory bulb external plexiform layer morphology J:82113
abnormal olfactory bulb layer morphology J:82113
abnormal olfactory bulb mitral cell layer morphology J:82113
abnormal otic capsule morphology J:71687
abnormal sensory neuron innervation pattern J:71687
abnormal skeleton morphology J:82113
abnormal tectorial membrane morphology J:71687
cochlear ganglion degeneration J:71687
decreased body weight J:71687, J:82113
delayed bone ossification J:82113
delayed inner ear development J:71687
disproportionate dwarf J:71687
increased neuron apoptosis J:71687
increased or absent threshold for auditory brainstem response J:105536
increased type II pneumocyte number J:82113
muscle hypoplasia J:82113
postnatal growth retardation J:71687
postnatal lethality, incomplete penetrance J:82113, J:105536
sensorineural hearing loss J:105536
small cochlear ganglion J:71687
syndromic hearing loss J:105536
Igf1tm1Dlr/Igf1tm1Dlr
Tg(Alb1-cre)1Dlr/0
involves: 129/Sv * C57BL/6 * FVB/N
no abnormal phenotype detected J:69517
Igf1tm1Dlr/Igf1tm1Dlr
Tg(Alb1-cre)1Dlr/0
involves: 129/Sv * C57BL/6J * FVB/N
decreased circulating insulin-like growth factor I level J:155733
decreased tumor growth/size J:155733
increased circulating leptin level J:155733
Igf1tm1Dlr/Igf1tm1Dlr
Tg(EIIa-cre)C5379Lmgd/0
involves: 129/Sv * C57BL/6 * FVB/N
fetal growth retardation J:49468
perinatal lethality, incomplete penetrance J:49468
slow postnatal weight gain J:49468
Igf1tm1Dlr/Igf1tm1Dlr
Tg(Mx1-cre)1Cgn/0
involves: 129/Sv * C57BL/6 * CBA
decreased circulating insulin-like growth factor I level J:55718, J:121798
decreased kidney weight J:121798
normal growth/size/body region phenotype J:55718, J:121798
normal homeostasis/metabolism phenotype J:121798
increased circulating growth hormone level J:121798
increased systemic arterial systolic blood pressure J:121798
increased urine potassium level J:121798
increased urine sodium level J:121798
normal renal/urinary system phenotype J:121798
Igf1tm1Dlr/Igf1tm1Dlr
Tg(Serpina1e-cre/ERT)1Sykr/0
involves: 129/Sv * C57BL/6J * FVB/N
decreased circulating insulin-like growth factor I level J:155733
normal homeostasis/metabolism phenotype J:155733
increased circulating insulin level J:155733
increased circulating leptin level J:155733
normal neoplasm J:155733
Igf1tm1Ts/Igf1+
involves: 129S7/SvEvBrd * C57BL/6J
abnormal postnatal growth/weight/body size J:16214
Igf1tm1Ts/Igf1tm1Ts
involves: 129S7/SvEvBrd * C57BL/6J
abnormal brain morphology J:24953
abnormal embryonic growth/weight/body size J:16214
abnormal muscle morphology J:16214
abnormal nervous system physiology J:24953
abnormal respiratory system morphology J:16214
abnormal respiratory system physiology J:16214
perinatal lethality J:16214
Igf1tm2.1Arge/Igf1tm2.1Arge
involves: 129S/SvEv * C57BL/6J * CBA
decreased body weight J:142247
decreased circulating insulin-like growth factor I level J:142247
Igf1tm2.1Nros/Igf1+
involves: BALB/c * C57BL/6
decreased birth weight J:159167
Igf1tm2.1Nros/Igf1tm2.1Nros
involves: BALB/c * C57BL/6
abnormal lung morphology J:159167
decreased birth weight J:159167
neonatal lethality, complete penetrance J:159167
primary atelectasis J:159167
respiratory failure J:159167
Igf1tm2Arge/Igf1tm2.1Arge
involves: 129S/SvEv * C57BL/6J * CBA
decreased body weight J:142247
decreased circulating insulin-like growth factor I level J:142247
Igf1tm2Arge/Igf1tm2.1Arge
Tg(SERPINA1-cre)1Arge/0
involves: 129S/SvEv * C57BL/6J * CBA
decreased body weight J:142247
decreased circulating insulin-like growth factor I level J:142247
Igf1tm2Arge/Igf1tm2Arge
involves: 129S/SvEv * C57BL/6J
abnormal long bone epiphyseal plate proliferative zone J:142247
decreased body weight J:142247
decreased circulating insulin-like growth factor I level J:142247
decreased long bone epiphyseal plate size J:142247
decreased survivor rate J:142247
infertility J:142247
neonatal lethality, incomplete penetrance J:142247
postnatal growth retardation J:142247
Igf1tm2Arge/Igf1tm2Arge
Tg(SERPINA1-cre)1Arge/0
involves: 129S/SvEv * C57BL/6J
decreased body weight J:142247
decreased circulating insulin-like growth factor I level J:142247
decreased survivor rate J:142247
neonatal lethality, incomplete penetrance J:142247
normal reproductive system phenotype J:142247
Igf1tm2Ts/Igf1tm2Ts
involves: 129S7/SvEvBrd * C57BL/6J
decreased body weight J:37969
decreased circulating glucose level J:37969
decreased circulating growth hormone level J:37969
increased heart left ventricle muscle contractility J:37969
increased systemic arterial blood pressure J:37969
increased systemic arterial diastolic blood pressure J:37969
increased systemic arterial systolic blood pressure J:37969

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory